Ananth V. Annapragada, PhD
Ananth Annapragada is Professor of Radiology and Obstetrics & Gynecology, Member of the Dan L. Duncan Comprehensive Cancer Center, and Director of Basic Research in the Edward B. Singleton Department of Pediatric Radiology at Texas Children's Hospital. Previously, he was the Robert Graham Professor of Entrepreneurial Biomedical Informatics and Bioengineering at the School of Biomedical Informatics at the University of Texas, Health Sciences Center at Houston. He holds additional positions at the Keck Institute, The University of Houston, Rice University and the University of Texas at Austin.
Ananth received his Ph.D. in Chemical Engineering from The University of Michigan in 1989. After postdoctoral fellowships at the University of Minnesota and MIT, he joined Abbott Laboratories as a Research Scientist in 1991. In 1996, he joined SEQUUS Pharmaceuticals, Menlo Park, CA and stayed on till it was acquired by Johnson and Johnson. In 2000, he started his first academic position at the Cleveland State University and Cleveland Clinic Foundation. In 2003, he moved to University of Texas and subsequently, joined Texas Children's Hospital in June 2011.
Dr. Annapragada's research interests include the development of nanomaterial based solutions to medical and imaging problems, 3d bioprinting, and the applications of AI in medicine.
Annapragada, A. V. et al. A natural language processing and deep learning approach to identify child abuse from pediatric electronic medical records. PLoS ONE 16, e0247404 (2021).
Ghaghada, K. B. et al. Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol ATVBAHA120315210 (2021). doi:10.1161/ATVBAHA.120.315210.
Orman, G. et al. Neuroimaging Offers Low Yield in Children Positive for SARS-CoV-2. American Journal of Neuroradiology 42, 951–954 (2021).
Devkota, L. et al. Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics. Sci Adv 6, eaba6156 (2020).
Annapragada, A. et al. Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer. J Immunother Cancer 8, e000796 (2020).
Tanifum, E. A. et al. A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging 2018, 1693513–8 (2018).
Badachhape, A. A. et al. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta 77, 1–7 (2019).
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.